Here are the stocks added to the Zacks #1 Rank ("strong buy") List today:

Adeona Pharmaceuticals Inc (AEN) Ajinomoto Co Inc (AJINY) Alleghany Corp (Y) Amerisafe Inc (AMSF) Anesiva Inc (ANSV) APAC Customer Services Inc (APAC) Atmos Energy Corp (ATO) British Airways plc (BAIRY) Cell Therapeutics Inc (CTIC) China Information Security Tech Inc (CPBY) Crawford & Co (CRD.B) EF Johnson Technologies Inc (EFJI) FiberTower Corp (FTWR) Flanders Corp (FLDR) Investors Bancorp Inc (ISBC) Kirkland's Inc (KIRK) Metabasis Therapeutics Inc (MBRX) NCI Inc (NCIT) NUCRYST Pharmaceuticals Corp (NCST) Parlux Fragrances Inc (PARL) Pegasystems Inc (PEGA) Pharmaxis Ltd (PXSL) S1 Corp (SONE) Saga Communications Inc (SGA) The J.M. Smucker Co (SJM) Sumitomo Mitsui Financial Grp Inc (SMFJY) Sutor Technology Group Ltd (SUTR) Techne Corp ...

Parlux Fragrances, Inc. (PARL), which has no debt, offers an attractive forward P/E ratio of 7. The company's price-to-book is at 0.62, well below the industry average of 1.3.

Company Description

Parlux Fragrances is a Florida-based manufacturer of designer fragrances under the brands of Paris Hilton, Jessica Simpson, GUESS?, Nicole Miller, Natori, Queen Latifah, XOXO, Ocean Pacific (OP), Andy Roddick, and Fred Hayman Beverly Hills. The company also has licenses for Paris Hilton watches, cosmetics, sunglasses, handbags and small leather accessories.

Parlux, a Zacks #1 Rank (strong buy), distributes its products in the U.S. through department and specialty stores and internationally to more than 90 countries through department stores and perfumeries.

Recent Events

The company just announced the signing of a worldwide licensing agreement with Marc Ecko Enterprises to develop and market a line of prestige fragrances for men and women.

Parlux management stated that Marc Ecko is the global leader

...

Ferro Corporation (FOE), the specialty chemical manufacturer, recently announced it was selling its fine chemicals business to Novolyte Technologies LP for $66 million in cash. The company said the proceeds will be used to pay down debt.

The business manufactures electrolytes used to make lithium batteries as well as specialty solvents. Novolyte will absorb the manufacturing employees.

Ferro, a Zacks #1 Rank (Strong Buy), continues to have strong fundamentals.

On Aug 5, it reported second quarter earnings that beat Wall Street estimates by 31.25%. Sales rose 17% to $650 million from $553.7 million in the year ago period.

Consensus estimates for the third quarter are steady at 31 cents per share. Full year estimates are up 5 cents to $1.38 in the last 60 days. Analysts expect 2008 year-over-year earnings per share growth of 62.65%.

Ferro is now trading at 10.5x forward earnings. Its price-to-book is

...